The ␣͞ T cell receptor complex transmits signals from MHC͞ peptide antigens through a set of constitutively associated signaling molecules, including CD3-͞␥ and CD3-͞␦. We report the crystal structure at 1.9-Å resolution of a complex between a human CD3-͞␦ ectodomain heterodimer and a single-chain fragment of the UCHT1 antibody. CD3-͞␦ and CD3-͞␥ share a conserved interface between the Ig-fold ectodomains, with parallel packing of the two G strands. CD3-␦ has a more electronegative surface and a more compact Ig fold than CD3-␥; thus, the two CD3 heterodimers have distinctly different molecular surfaces. The UCHT1 antibody binds near an acidic region of CD3-opposite the dimer interface, occluding this region from direct interaction with the TCR. This immunodominant epitope may be a uniquely accessible surface in the TCR͞CD3 complex, because there is overlap between the binding site of the UCHT1 and OKT3 antibodies. Determination of the CD3-͞␦ structure completes the set of TCR͞CD3 globular ectodomains and contributes information about exposed CD3 surfaces.antibody-binding site ͉ CD3 ͉ T cell receptor T he ␣͞ T cell receptor (TCR) is a multimeric cell-surface complex comprising a clonotypic antigen-binding TCR heterodimer and three conserved signal transducing modules: CD3-͞␥ and CD3-͞␦ heterodimers and a TCR-homodimer (1-3). TCR͞CD3 chains assemble into a minimal eight-subunit complex in the endoplasmic reticulum through a series of dimeric and trimeric interactions with a stoichiometry of one TCR-␣͞ heterodimer, one CD3-͞␥ heterodimer, one CD3-͞␦ heterodimer, and a TCR-homodimer (4-8). Whereas extracellular contacts are sufficient for interactions within TCR and CD3 heterodimers (9-12), transmembrane interactions are necessary for assembly and surface expression of intact TCR͞CD3 complexes (7,(13)(14)(15)(16)(17)(18). Extracellular domains of CD3 may provide additional specificity to mandatory transmembrane interactions (8,19,20), but specific extracellular interactions between TCR and CD3-͞␦ or CD3-͞␥ have yet to be determined.Antibodies to CD3, first used to identify and characterize T cells, are effective laboratory tools for activation of many pathways in the T cell signaling cascade. One such antibody is UCHT1 (21). Fusions of UCHT1 with immunotoxins are being used for targeted T cell depletion in animal models of organ transplantation (22). UCHT1 and several other anti-CD3 antibodies, including OKT3, recognize epitopes on CD3-found in heterodimers with CD3-␦ and with CD3-␥, but not CD3-expressed in isolation (23). Understanding the specific interactions between UCHT1 and CD3 may facilitate development of this or other antibodies as clinical agents. Moreover, because UCHT1 immunoprecipitates all TCR and CD3 components, it is a good tool for studying accessible surfaces of CD3 in the TCR͞CD3 complex.Detailed structural knowledge of the TCR͞CD3 complex is important for understanding how the TCR transmits the signal it receives from its MHC͞peptide ligand. The structure of the TCR͞CD3 complex and its relati...